Jeffrey Rade to Follow-Up Studies
This is a "connection" page, showing publications Jeffrey Rade has written about Follow-Up Studies.
Connection Strength
0.267
-
Qureshi WT, Kakouros N, Fahed J, Rade JJ. Comparison of Prevalence, Presentation, and Prognosis of Acute Coronary Syndromes in =35 years, 36 - 54 years, and = 55 years Patients. Am J Cardiol. 2021 02 01; 140:1-6.
Score: 0.123
-
Gluckman TJ, McLean RC, Schulman SP, Kickler TS, Shapiro EP, Conte JV, McNicholas KW, Segal JB, Rade JJ. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol. 2011 Mar 01; 57(9):1069-77.
Score: 0.063
-
Gluckman TJ, Segal JB, Fredde NL, Saland KE, Jani JT, Walenga JM, Prechel MM, Citro KM, Zidar DA, Fox E, Schulman SP, Kickler TS, Rade JJ. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization. Am J Cardiol. 2005 Mar 15; 95(6):744-7.
Score: 0.042
-
Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, Meraj PM, Garberich R, Jaffer FA, Stefanescu Schmidt AC, Dixon SR, Rade JJ, Smith T, Tannenbaum M, Chambers J, Aguirre F, Huang PP, Kumbhani DJ, Koshy T, Feldman DN, Giri J, Kaul P, Thompson C, Khalili H, Maini B, Nayak KR, Cohen MG, Bangalore S, Shah B, Henry TD. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 08 01; 98(2):217-222.
Score: 0.030
-
Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, Kleiman N. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47.
Score: 0.009